Erasmus, E., Mienie, L
I mean, work smarter, not harder, right
2 Kidney Disease Risk Reduction In addition, the FDA has approved semaglutide (Ozempic) to slow the progression of kidney disease and reduce the risk of kidney failure, making it the most widely indicated GLP-1 drug
Dysbiosis, or microbial imbalance, is believed to disrupt this axis, leading to alterations in gut motility, pain sensitivity, and immune responses, which are common in conditions like IBS and IBD
Yeah, three times a week
Infrequent and mild side effects might include abdominal cramping, bloating, and stomach upset